Edgardo Yordan, MD, FACOG, FACS

Curriculum Vitae

Chairman
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
John Stroger Cook County Hospital
1900 W. Polk Street, Room 546
Chicago, IL 60612

Associate Professor
Rush University Medical Center
Department of Obstetrics and Gynecology
Gynecologic Oncology Section
1653 W. Congress Parkway
Chicago, IL 60612

EDUCATION


College: Columbia University BA, 1968
New York, NY

Medical School: University of Maryland MD, 1972
Baltimore, MD

Internship: University of Chicago 1972-1973
Chicago, IL

Residency: Columbia-Presbyterian
Medical Center 1973-1976
Elected Chief Resident 1976-1977
New York, NY

Galloway Fellowship in Gynecologic Oncology
Memorial Sloan-Kettering Cancer Institute
New York, NY, July-August, 1976

Fellowship in Gynecologic Oncology, LA County/University of Southern California,
Los Angeles, CA, 1977-1979
Faculty: C. Paul Morrow, Duane Townsend, Philip DiSaia, John Schlaerth, Richard Nalick, William Rich, James Nolan, and Wilfred Hernandez

BOARD CERTIFICATIONS

I. American Board of Obstetrics and Gynecology, 1980

II. Certificate of Special Competence, Gynecologic Oncology, 1983

LANGUAGES

English
Spanish
French 

ACADEMIC APPOINTMENTS

I. Clinical Instructor in OB/GYN, LAC/University of Southern California Medical Center, 1977-1979

II. Assistant Professor of Obstetrics and Gynecology, Columbia University, College of Physicians and Surgeons, 1979-1980

III. Assistant Professor of Obstetrics and Gynecology, Rush University Medical College, 1980-1989

IV. Instructor of Obstetrics & Gynecology, University of Illinois School of Medicine, 1986-1995

V. Associate Professor of Obstetrics and Gynecology, Rush Medical College, 1989-Present

HOSPITAL APPOINTMENTS

University of Southern California – Los Angeles County Medical Center, 1977-1979

California Hospital and Medical Center, 1977-1979

Columbia-Presbyterian Medical Center, 1979-1980

St. Luke’s-Roosevelt Medical Center, 1979-1980

Harlem Hospital, 1979-1980

Rush University Medical Center, 1980-present

Christ Hospital, 1980-1998

Grant Hospital, 1981-1998

Central DuPage Hospital, 1982-2005

University of Illinois Medical Center, 1987-1995

Rush North Shore Medical Center, 1988-present

Lutheran General Hospital, 1995-present

John Stroger Hospital of Cook County, 2003-present

Mercy Hospital, 2005-present 

ADMINISTRATIVE APPOINTMENTS

John Stroger Hospital Cook County
Division Chairman, Gynecologic Oncology, 2003-present

Mercy Hospital and Medical Center
Director, Division of Gynecologic Oncology, 2007-2009

Oak Brook Institute of Endoscopy
Co-Director, 1995-Present

Rush University Medical Center
Director, Section Gynecologic Oncology, 1980-1995
Associate Chairman, Department of Obstetrics and Gynecology, 1987-1995

Lutheran General Hospital
Director, Division of Gynecologic Oncology, 1995-2003
Vice Chairman, Department of Obstetrics and Gynecology, 2000-2003

Illinois Cancer Council
Chairman, Gynecologic Committee, 1986-1988

Gynecologic Oncology Group
Co-Principal Investigator, 1985-1988
Principal Investigator, 1988-5/95
Ovarian Committee, 1982-1989
Membership Committee, 1985-1999

American College of Surgeons
Committee on Applicants, 1989-2003

Association of Chicago Gynecologic Oncologists
Secretary/Treasurer, 1982-85
President, 1993-95

Western Association of Gynecologic Oncologists
Vice-President, 1993

SPECIAL RECOGNITION

Rush University Medical Center
Resident’s Special Recognition Award, 1990
Resident’s Special Recognition Award, 1995

Mercy Hospital and Medical Center
APGO Resident Teaching Award, (Association of Professors of Gynecology & Obstetrics), 2009

Lutheran General Hospital
“National Faculty Award”, Resident’s CREOG (Council Resident Education in Obstetrics & Gynecology), 1999

Good Housekeeping Magazine
“Best 400 Cancer Doctors in USA”, October 1992

CHICAGO Magazine
“Chicago’s Top Doctors”, January 1997

Good Housekeeping
“Best 400 Doctors in USA for Women”, August 1997

Who’s Who in America

Castle-Connolly Guide
Top Doctors in Chicago Metro Area, 1999-Present

American Society for Colposcopy & Cervical Pathology
Representative to Liaison Committee, 1996-1998

VIDEO PRESENTATION AWARDS


Best Production: Laparoscopic Hysterectomy. 1st International Gynecologic Endoscopy Film Festival, American Association of Gynecologic Laparoscopists (AAGL). San Diego, California. August 1993.

Second Place: Laparoscopic Hysterectomy II. 22nd World Congress of Gynecologic Endoscopy, American Association of Gynecologic Laparoscopists (AAGL). San Francisco, California. November, 1993.

First Place, Golden Laparoscope Award: Laparoscopic Pelvic Lymphadenectomy. 2nd International Gynecologic Laparoscopy Film Festival, American Association of Gynecologic Laparoscopists (AAGL). San Diego, California. July, 1994.

First Place, Best Instructional Video: Laparoscopic Pelvic Lymphadenectomy. 2nd International Gynecologic Laparoscopy Film Festival, American Association of Gynecologic Laparoscopists (AAGL). San Diego, California. July, 1994.

Honorable Mention, Gynecology Video: Laparoscopic Hysterectomy for the Enlarged Uterus. 16th Annual Meeting, Society of Laparoendoscopic Surgeons (SLS). San Francisco, California. September, 2007.

Finalist, WebSurg Award in Minimally Invasive Surgery Videos: Laparoscopic Tubal Anastomosis. WebSurg 2007 Awards, Institut de Recherche contre les Cancers de l'Appareil Digestif/European Institute of TeleSurgery (IRCAD/EITS). Strasbourg, France. December, 2007.

Honorable Mention, Gynecology Video: Laparoscopic Tubal Anastomosis. 17th Annual Meeting, Society of Laparoendoscopic Surgeons (SLS). San Francisco, California. September, 2008.

First Prize, 2009 ACOG Film Festival: Alternatives to Hysterectomy. 57th Annual Meeting, American College of Obstetricians and Gynecologists (ACOG). Chicago, Illinois. May, 2009.

Please also see “Video Presentations” section of CV for details of listed awards in video presentations of laparoscopic surgeries. Videos may be viewed online at: www.OakBrookEndoscopy.com

PROFESSIONAL SOCIETIES

1. Fellow, American College of Obstetricians and Gynecologists
2. Fellow, American College of Surgeons
3. The Society of Gynecologic Oncologists
4. Chicago Gynecologic Society
5. Western Association of Gynecologic Oncologists, Vice President 1993
6. American Society of Clinical Oncologists
7. Association of Professors of Gynecology and Obstetrics
8. Association of Chicago Gynecologic Oncologists
9. Illinois State Medical Society
10. Chicago Medical Society
11. International Gynecologic Cancer Society
12. Central Association of Obstetricians and Gynecologists
13. American Society of Colposcopy and Cervical Pathology Liaison Committee, 1992-1998
14. Central Travel Club
15. Asociación Argentina de Ginecología Oncológica

EDITORIAL CONSULTATION

Professional Peer Review for Journals:
- Gynecologic Oncology
- Cancer
- American Journal of Obstetrics & Gynecology
- Obstetrics & Gynecology
- Journal of the International Federation of Gynecologists and Obstetricians
- Journal of the American College of Surgeons

COMMUNITY AFFAIRS

Educational Philanthropy:
- Board of Trustees, Midtown Educational Foundation, Chicago, 1988-1989
- Medical Mission, San Pedro de Macorí, Santo Domingo, 2006

Middle East Philanthropy:
- Equestrian Order of the Holy Sepulchre of Jerusalem, 1999 - present, Knight of the Order of the Holy Sepulchre. Promoted to Knight Commander of the Holy Sepulchre, 2006

Local/National/International Philanthropy:
- Sovereign Military Hospitaller Order of St. John of Jerusalem, of Rhodes, and of Malta, 2006 – present, Knight of Malta, Sovereign Order of Malta
- Full member, Comité International Medical de Lourdes (CMIL), Medical advisory committee to Bishop Perrier of Lourdes, Sanctuary of Lourdes, Lourdes, France, 2007 - present

PUBLICATIONS

1. Yordan EL, Quirk JG, Petrie RH: A Near-Fatal Case of Placenta Percreta. American Journal of Obstetrics and Gynecology, 129:462, 1977.

2. Pazdur, R. Bonomi PD, Gould VE, Yordan EL, Roseman D, Hollinger L: Neuroendocrine Small Cell Carcinomas in Miscellaneous Primary Sites. Anti-Cancer Research, 1:335-340, 1981.

3. Stassart J, Crum CP, Yordan EL, Fenoglio CM, Richart RM: Argyrophilic Carcinoma of the Cervix: A Report of a Case with Coexisting Cervical Intraepithelial Neoplasia. Gynecologic Oncology, 13:247-251, 1982.

4. Margolick J, Bonomi PD, Fordham E, Yordan EL, Slayton RE, Wilbanks GD: Case Report – Hypertrophic Osteoarthropathy Associated with Endometrial Carcinoma. Gynecologic Oncology, 13:399-404, 1982.

5. Yordan EL, Schlaerth J, Gaddis O, Morrow CP: Radiation Therapy in the Management of Gestational Choriocarcinoma Metastatic to the Central Nervous System. Obstet & Gynecol. 69:627, April 1987.

6. Muss HB, Bundy B, DiSaia PJ, Homesley HD, Fowler WC, Wesley C, Creasman W and Yordan EL. Treatment of Recurrent or Advanced Uterine Sarcoma: A Randomized Trial of Doxorubicin Versus Doxorubicin and Cyclophosphamide (A Phase III Trial of the Gynecologic Oncology Group). Cancer #8, 55:1648-1653, April 1985.

7. Morrow CP, Creasman WT, Homesley H, Yordan E, Park R, Bundy B: Recurrence in Endometrial Carcinoma as a Function of Extended Surgical Staging Data (A Gynecologic Oncology Group Study). In Gynaecologic Oncology, Morrow CP & Smart GE, Eds., Springer-Verlag, N.Y. (Chapter 15) 147-153, 1985.

8. Stehman FB, Blessing JA, Homesley HD, Currie JL, and Yordan EL. Phase II Evaluation of Dianhdrogalactitol in the Treatment of Advanced Non-squamous Cervical Carcinoma: A Gynecologic Oncology Group Study. Investigational New Drugs, Issue 3, 2:331-333 Fall, 1984.

9. Omura G, Blessing J. Ehrlich EC, Miller AW, Yordan EL, Creasman WT, and Homesley HD: A Randomized Trial of Cyclophosphamide and Doxorubicin with or without Cisplatin in Advanced Ovarian Carcinoma: A Gynecologic Oncology Group Study. Cancer #9, 57:1725-1720, May 1986.

10. Reddy S, Lee MS, Graham JE, Yordan EL, Phillips R, Saxena VS, Hendrickson FR, Wilbanks GD. Radiation therapy in primary carcinoma of the vagina. Gynecologic Oncology #1, 26:19-24, January 1987.

11. Reddy S, Saxena VS, Lee MS, Yordan EL, Graham JE, Phillips R, Wilbanks GD. Results of radiotherapeutic management of primary carcinoma of the vagina. Gynecologic Oncology #1, 32:112, January, 1989.

12. Reddy S, Hartsell W. Graham JE, Yordan EL, Lee MS, Pramilla S, Phillips AK, McIntosh D, Wilbanks GD: Whole-Abdomen Radiation Therapy in Ovarian Carcinoma: Its Role as a Salvage Therapeutic Modality. Gynecologic Oncology #35, 3:307-313, December 1989.

13. Pazdur R, Bonomi P, Gould VE, Yordan EL, Roseman D, Holinger L, Kittle FC: Neuroendocrine Small Cell Carcinomas in Miscellaneous Primary Sites: Implications for Staging and Therapy. Anticancer Research 1:335-340, 1981.

14. Bonomi P, Yordan E, Blessing J: Phase I Trial of Cisplatin and Razoxand (ICRF-159) (NSC#1198755) in Advanced Squamous Cell Carcinoma of the Cervix. (A Gynecologic Oncology Group Pilot Study). American Journal of Clinical Oncology: Cancer Clinical Trials #1, 11:1-2, February 1988.

15. Yordan EL, Jurado M, Kiel K, Reddy S, Kramer T, Calvo F, Roseman DL, Graham J, Wilbanks GD: Intra-operative Radiation Therapy in the Treatment of Pelvic Malignancies: A Preliminary Report. Balliere’s Clinical Obstetrics and Gynaecology, Bailliere Tindall, London, Vol. 2, #4, Chapter 27, pp. 1023-1034, December 1988.

16. Yordan EL, Jurado M, Kiel K, Reddy S, Kramer T, Calvo F, Roseman D, Graham J, Wilbanks G. Intraoperative radiation therapy (IORT) in pelvic malignancies. Gynecologic Oncology #1, 32:117-122, January 1989.

17. Muss HB, Bundy BN, Yazigi R, Yordan E: Teniposide (VM-26) in Squamous Cell Carcinoma of the Cervix: Phase II Trial of the Gynecologic Oncology Group. Cancer Treatment Reports, #9, 71:873-874, November 1987.

18. Sedlis A, Homesley H, Bundy b, Marshall R, Yordan E, Hacker N, Lee J, Whitney C: Positive Groin Lymph Nodes in Superficial Squamous Cell Vulvar Cancer (A Gynecologic Oncology Group Study). American Journal of Obstetrics & Gynecology #5, 156:1559-1164, May 1987.

19. McGuire WP, Blessing JA, Yordan E, Beecham J: Phase II Study of Esorubicin (4, Deoxydoxorubicin) in Advanced or Metastatic Squamous Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study. Investigational New Drugs #2-3, 7:235-238, June 1989.

20. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, Mortel R: Prognostic Factors for Groin Node Metastasis in Squamous Cell Carcinoma of the Vulva (A Gynecologic Oncology Group Study). Gynecologic Oncology #3, 49:279-283, June 1993.

21. Thigpen T, Blessing JA, DiSaia PJ, Yordan E, Carson LF, Evers C: A Randomized Comparison of Doxorubicin Alone Versus Doxorubicin Plus Cyclophosphamide in the Management of Advanced or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study. Submitted for publication

22. Singh P, Yordan EL, Graham JR, Wilbanks GD, Slayton RE, Miller AW: Combination Chemotherapy for Malignant Mixed Germ Cell Tumours of the Ovary: A Prospective Study. Asia-Oceanic J. Obstet. Gynaecol #2, 14:137-142, 1988.

23. Singh P, Yordan EL, Wilbanks GD, Miller AW, Wee A: Malignancy Associated with Benign Cystic Teratomas (Dermoid Cysts) of the Ovary. Asia-Oceanic J. Obstet. Gynae., 1988

24. Singh P, Yordan EL, Graham JR, Wilbanks GD, Slayton RE, Miller AW, Ratnam SS: Combination Chemotherapy for Immature (Malignant) Teratomas of the Ovary. Asia-Oceania J. Obstet, Gynaec., 1988

25. Heaton D, Yordan EL, Reddy S, Bonomi P, Lee MS, Lincoln S, Graham J, Dolan T, Miller A, Phillips A, Kirschner C, Bergen S, Wilbanks G. Treatment of 29 Patients with Bulky Squamous Cell Carcinoma of the Cervix with Simultaneous Cisplatin, 5-Flourouracil, and Split Course Hyperfractionated Radiation Therapy. Gynecol. Oncol. 38;323-327, September 1990.

26. Brinton L, Nasca P, Mallin K, Schairer C, Rosenthal J, Rothenberg R, Yordan E, Richart R: Case-control study of in situ and invasive carcinoma of the vagina. Gynecol. Oncol., 38:49-54, July 1990.

27. Bergen S, Graham J, Yordan E, Lincoln S, Wilbanks G; Mitomycin C and 5-Fluorouracil as Second-Line Treatment for Recurrent or Progressive Ovarian Cancer. Gynecol. Oncol., submitted 1990.

28. Creasman WT, Omura GA, Brady MF, Yordan E, DiSaia PJ, Beecham J. A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: A Gynecologic Oncology Group Study. Gynecologic Oncology #3, 39:239-243, December, 1990.

29. Reddy S, Lee MS, Yordan E, Graham J, Sarin P, Hendrickson FR: Salvage whole abdomen radiation therapy: its role in ovarian cancer. International Journal of Radiation Oncol Biol Phys, 27(4):879-84, November, 1993.

30. Homesley H, Bundy B, Sedlis A, Yordan E, Berek J, Johnson A, Mortel R: Assessment of current International Federation of Gynecology and Obstetrics (FIGO) staging of vulvar carcinoma relative to prognostic factors for Survival (a Gynecologic Oncology Group Study). Am J Obstet Gynecol, 164(4):997-1003, April, 1991.

31. Omura G, Brady M, Homesley H, Yordan E, Major F, Buchsbaum H, Park R: Long Follow-up and Prognostic Factor Analysis in Advanced Ovarian Carcinoma: The Gynecologic Oncology Group Experience. J. Clin. Oncol. 9(7):1138-50, 1991.

32. Boente M, Yordan E, McIntosh D, Grendys E, Orandi Y, Davies S, Beck D, Graham J, Miller A, Marshall R, Dolan T, Kirschner C, Reddy S, and Wilbanks G: Prognostic Factors and Long-Term Survival in Stage II Endometrial Carcinoma. Gynecol. Oncol. 51:316-322, December 1993.

33. Markman M, Hakes T, Reichman B, Hoskins W, Rubin S, Almadrones L, Yordan EL, Eriksson J, Lewis J. Phase 2 trial of intraperitoneal (ip) cisplatin (C) and ara-C (A) in refractory ovarian carcinoma (ROC). Gynecologic Oncology #2, 36:290, February 1990.

34. Markman M, Hakes T, Reichman B, Hoskins W, Rubin S, Jones W, Almadrones L, Yordan E, Eriksson J, Lewis J. Intraperitoneal Cisplatin and Cytarabine in the Treatment of Refractory or Recurrent Ovarian Carcinoma. J. Clin. Oncol. 9:2:204, February 1991.

35. Sutton G, Bundy B, Omura G, Yordan E, Beecham J, Bonfiglio T: Stage III Ovarian Tumors of Low Malignant Potential (LMP) Treated With Cisplatin Combination Therapy (A Gynecologic Oncology Group Study). Gynec. Oncol. 32:102-103, January 1989.

36. Perlow JH, Wigton T, Yordan EL, Graham J, Wool N, Wilbanks GD: Disseminated Pelvic Actinomycosis Presenting as Metastatic Carcinoma: Association with the Progestasert Intrauterine Device. Reviews of Infectious Diseases 13:1115-9, November-December 1991.

37. Thigpen JT, Blessing JA, Beecham J, Homesley H, Yordan E: Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol, 9(11):1962-6, November, 1991.

38. Morgan JD, Reddy S, Sarin P, Yordan E, De Geest K, Hendrickson FR. Isolated Vaginal Recurrences of Endometrial Carcinoma. Radiology, 189:2;609-613, November 1993.

39. Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, Currie JL. Yordan E, and Brady MF. Prognostic Factors in Early-Stage Uterine Sarcoma. A Gynecologic Oncology Group Study. Cancer, 72:4;1702-1709, February 15, 1993.

40. Boente MP, Orandi YA, Yordan EL, McIntosh DG, Graham JE, Kirschner CV, and Wilbanks GD. Recurrence Patterns and Complications in Endometrial Adenocarcinoma with Cervical Involvement. Annals of Surgical Oncology, 2(2):138-44, March, 1995.

41. Behbakht K, Massad LS, Yordan EL, Lincoln SH, Eriksson JH, Winkelman L, De Geest K, Kirschner C, Wilbanks GD. A Bleomycin/Ifosfamide/Cisplatin Regimen Exhibits Poor Activity Against Persistent or Recurrent Squamous Gynecologic Cancers. European Journal of Gynecologic Oncology, 17(1):7-12, 1996.

42. Behbakht K, Yordan EL, Casey C, De Geest K, Massad LS, Kirschner CV, and Wilbanks GD. Prognostic Indicators of Survival in Advanced Endometrial Cancer. Gynecologic Oncology #3, 55:363-367, December, 1994.

43. Massad LS, Wagley E, Winkelman L, Lincoln S, Yordan EL, De Geest K, Wilbanks GD. Salvage Mitomycin/5-Flourouracil after Platinum-based Therapy for Women with Advanced Ovarian Cancer and Related Gynecologic Malignancies. Eur J Gynael Oncol 15(5):337-342, 1994.

44. Kirschner CV, Yordan EL, De Geest K, and Wilbanks GD: Smoking, Obesity, and Survival in Squamous Cell Carcinoma of the Vulva. Gynecologic Oncology #1, 56:79-84, January 1995.

45. Thigpen T, Blessing JA, Yordan E, Valea F, Vaccarello L. Phase II Trial of Etoposide in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study, Gynecologic Oncology #1, 63:120-122, October 1996.

46. Granados LM, Chiva LM, Yordan EL, Lopez-Garcia N. Cancer Familiar De Ovario Y Carcinoma De Trompa. Papel De La Salpingooforectomia Bilateral Profilactica (Familial Ovarian Cancer and Tube Carcinoma. Role of the Prophylactic Bilateral Salpingoophorectomy). Progresos De Obstetricia Y Ginecologia (Spain), Volume 40, #5, pp. 370-372, 1997.

47. Williams L, Brunetto V, Yordan E, DiSaia P, Creasman W. Secondary Cytoreductive Surgery at Second-Look Laparotomy in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study. Gynecologic Oncology #2, 66:171-178, August 1997.

48. Elnaggar MJ, Zusag TW, Rotmensch J, Yordan E, Abrams RA. Toxicity from bowel perforation in interstitial implants for treatment of cancers of the gynecological tract. Proceedings of the American Brachytherapy Society, 25 April 2006

49. Howard AT, Yordan EL, Gown A, Rotmensch J, Kerrick H, Gattuso P, Bitterman P. Solitary metastasis to the spleen from an endometrial primary: A case report and review of the literature. Submitted for publication, 2007

SIGNIFICANT SCIENTIFIC PRESENTATIONS

1. Analysis of Cryotherapy Failures in 1000 cases of Cryotherapy for C.I.N. at the LAC/USC Medical Center, presented at the Western Association of Gynecologic Oncologists, June, 1978, Santa Barbara, California.

2. Central Nervous System Metastases of Gestational Trophoblastic Disease, presented at the Memorial Society of Gynecologic Oncologists, September, 1982, Montreal, Canada.

3. Peritoneovenous Shunting in the Management of Refractory Ascites in Gynecologic Malignancy, presented at the Annual Convention, American Society of Clinical Oncology, May, 1982, San Diego, California, October, 1982, Chicago, Illinois.

4. Curative Chemotherapy for Malignant Germ Cell Tumors of the Ovary, presented at the Western Association of Gynecologic Oncologists, 12th Annual Meeting, May, 1984, Sun River, Oregon.

5. Use of Clonogenic Assay in Chemotherapy of Gynecologic Malignancies, presented at the Western Association of Gynecologic Oncologists, 12th Annual Meeting, May, 1984, Sun River, Oregon.

6. Radiation Therapy in the Management of Gestational Choriocarcinomas Metastatic to the C.N.S., presented at the Second World Congress on Trophoblastic Neoplasms, November, 1984, Singapore.

7. Treatment of Advanced Pelvic Malignancies with
Simultaneous Cisplatin, 5-FU and Radiation Therapy, presented at the Symposium on Continuous Infusion Chemotherapy and its Interactions with Radiation in the Treatment of Malignant Tumors, State University of New York Downstate Medical Center, March, 1985, New York, New York.

8. Treatment of Advanced Pelvic Malignancies with Simultaneous Cisplatin, 5-FU and Radiation Therapy, presented at the Western Association of Gynecologic Oncologists, May, 1986, Monterey, California.

9. Intraoperative Radiation Therapy in the Treatment of Pelvic Malignancies, presented at the Society of Pelvic Surgeons, October, 1988, Rome, Italy.

10. Stage II Endometrial Carcinoma: A Review of Long Term Survival and Treatment Options. Presented at the Seventeenth Annual Meeting of the Western Association of Gynecologic Oncologists, Ramada Renaissance Hotel, May 17-20, 1989, San Francisco, California.

11. Vaginal Recurrences of Endometrial Carcinoma: Results of Treatment and Patterns of Failure. Presented at the Seventeenth Annual Meeting of the Western Association of Gynecologic Oncologists, Ramada Renaissance Hotel, May 17-20, 1989, San Francisco, California.

12. Treatment of Bulky Squamous Cell Carcinoma of Cervix (SCCCx) With Simultaneous Cisplatin (DDP), 5-Flourouracil (5FU), and Split-Course Hyperfractionated Radiation Therapy (SHR). Presented at the Annual Meeting of the Society of Gynecologic Oncologists. February 4-7, 1990, San Francisco, California.

13. Boente M, Yordan E,McIntosh D, Grendys E, Orandi Y, Davies S, Beck D, Graham J, Miller A, Marshall R, Dolan T, Kirschner C, Bergen S, Reddy S, and Wilbanks G. Prognostic Factors and Long-Term Survival In Stage II Endometrial Carcinoma. Presented at the 3rd Biennial Meeting of the International Gynecologic Cancer Society, September 24, 1991, Cairns, Australia.

INVITED ARTICLES & CHAPTERS

1. Yordan EL, Bernhard LA: The Surgeon’s Role in Wound Healing. Association of Operating Room Nurses Journal, 35:1078, 1982.

2. Yordan EL, Bonomi PD, and Wilbanks, GD: Chemotherapy of Vulvar and Vaginal Neoplasms. Editor, Gunther Deppe. Chemotherapy of Gynecologic Cancer. Alan R. Liss, New York, 1984.

3. Bonomi PD, and Yordan EL: Chemotherapy of Cervical Carcinoma. Editor, Gunther Deppe. Chemotherapy of Gynecologic Cancer. Alan R. Liss, New York, 1984.

4. Eriksson JH, Swenson KK, Greenberg R, Yordan EL: Your Guide To Intraperitoneal Chemotherapy, Oncology Nursing Forum 13(5):77, 1986.

5. Yordan E and Wilbanks GD: Carcinoma de Cervix, Patologia y Diagnostico. Editor, Santiago Dexeus. Tratado y Atlas de Patologia Cervical, Colposcopia, Microcolpohisteroscopia. Salvat, Barcelona, 1989.

6. Yordan E and Bonomi P: Chemotherapy of Vulvar and Vaginal Neoplasms. Editor, Gunther Deppe. Chemotherapy of Gynecologic Cancer, 2nd Edition. Alan R. Liss, New York, 1990.

7. Bonomi P and Yordan E: Chemotherapy of Cervical Carcinoma. Editor, Deppe. Chemotherapy of Gynecologic Cancer, 2nd Edition. Alan R. Liss, New York, 1990.

8. Yordan EL, Wilbanks GD, Dexeus S: Retroperitoneal Approach to Abdominal Hysterectomy, OB-GYN Illustrated, A Pictorial Review of Current Topics in Obstetrics & Gynecology, Upjohn, 1991.

9. Yordan EL, Wilbanks GD: Early Invasive Carcinoma of Cervix. Editors, Jordan J, Richart R, and Luesley D. Intraepithelial Neoplasia of the Lower Genital Tract. Churchill-Livingston, London, 1993.

10. Collaboration in preparation of: Staging of Gynecologic Malignancies, SGO Handbook, 1st Edition. Society of Gynecologic Oncologists, January, 1994.

11. Yordan EL: What’s New in Surgery 1998 (Obstetrics and Gynecology), Journal of the American College of Surgeons, 186:2;182-188, February, 1998.

12. Rotman C, Rana S, Song J, Yordan EL, Sueldo C: Laparoscopic Tubal Reanastomosis. Editors, Botros Rizk et al. Textbook of Infertility and Assisted Reproduction. Cambridge University Press, 2008.

POSTER SESSIONS

1. Yordan E, Straus A, Roseman D, Graham J, Wilbanks G. Peritoneovanous Shunting in the Management of Refractory Ascites From Gynecologic Malignancy. American Gynecological & Obstetrical Society, 1983.

2. Yordan E, Jurado M, Kiel K, Reddy S, Kramer T, Calvo F, Froseman D, Graham J, Wilbanks G: Intraoperative Radiation Therapy (IORT) in Pelvic Malignancies. Society of Gynecological Oncology, 1989.

3. Heaton D, Yordan E, Bonomi P, Reddy S, Graham J, Kirschner C, Bergen S, Lincoln S, Dolan T, Philips A, Eriksson J, Wilbanks G: Treatment of Bulky Squamous Cell Carcinoma of Cervix (SCCCx) With Simultaneous Cisplatin (DDP), 5-Flourouracil (5-FU) and Split-Course Hyperfractionated Radiation Therapy (SHRT). 21st Annual Meeting, Society of Gynecologic Oncologists, San Francisco, February 1990.

4. Grendys ED, Morris M, Wilbanks GD, Yordan EL, Rawlins RG. Creatinine Clearance as a Guide to Cisplatin-based Chemotherapy: Can a 24 Hour Urine Collection Be Eliminated? The International Gynecologic Cancer Society, Cairns, Australia, page 148, September 1991.

VIDEO PRESENTATIONS

1. Rotman C, Rana N, Hasson H, Yordan E: Laparoscopic Hysterectomy III, presented at the 23rd Annual Meeting of the American Association of Gynecologic Laparoscopists, October 18, 1994, New York, New York.

2. Yordan E, Rotman C, Rana N: Laparoscopic Pelvic Lymphadenectomy, presented at the 23rd Annual Meeting of the American Association of Gynecologic Laparoscopists, October 18, 1994, New York, New York. Awarded “Golden Laparoscope Award” (first prize), and “Best Educational Video” (second prize)

3. Sung J, Rotman C, Rana N, Yordan E, Sueldo C: Laparoscopic Hysterectomy for the Enlarged Uterus, presented at the 16th Annual Meeting of the Society of Laparoendoscopic Surgeons (SLS), September 2007, San Francisco, CA. Awarded “Honorable Mention” (second prize) among gynecologic video-presentations.

4. Sung J, Rotman C, Rana N, Yordan E, Sueldo C: Alternatives to Hysterectomy, presented at the Annual Meeting of the Society for Laparoendoscopic Surgeons, September 2007, San Francisco, CA.

5. Sung J, Rotman C, Rana N, Yordan E, Sueldo C: Laparoscopic Trachelectomy, presented at the Annual Meeting of the American Association of Gynecologic Laparoscopists, November 2007, Washington, DC.

6. Sung J, Rotman C, Rana N, Yordan E, Sueldo C: Laparoscopic Approach to the Large Cervical Leiomyoma, presented at the Annual Meeting of the American Association of Gynecologic Laparoscopists, November 2007, Washington, DC.

7. Song J, Rotman C, Yordan E, Sueldo C: Laparoscopic Tubal Anastomosis, presented at Institut de Recherche contre les Cancers de l’Appareil Digestif/European Institute of Telesurgery (IRCAD/EITS), December 2007, Strasbourg, France. Awarded Finalist, WebSurg 2007 Awards in Minimally Invasive Surgery Videos.

8. Song J, Rotman C, Yordan E, Sueldo C: Laparoscopic Tubal Anastomosis, presented at the 17th Annual Meeting of the Society of Laparoendoscopic Surgeons (SLS), September 2008, San Francisco, California. Awarded “Honorable Mention” (second prize) among gynecologic video-presentations.

9. Song J, Rotman C, Yordan E, Sueldo C: Alternatives to Hysterectomy 2, presented at the 57th Annual Meeting of the American College of Obstetricians and Gynecologists, May 2009, Chicago, Illinois. Awarded First Prize ACOG Film Festival.

ABSTRACTS

1. Leibach S, Miller N, Slayton RE, Graham JE, Miller A, Yordan EL, Wilbanks GD, Dunne C: Hormone Receptors in Ovarian Cancer, presented at the Annual Convention, American Association of Cancer Research, May 1983, San Diego, California.

2. Rossof AH, Johnson PA, Kimmell BD, Wilbanks GD, Yordan EL, Graham JE, Kittle CF, Economou SG: In Vitro Phase II Evaluation of Cis-Platin and Three Analogs Against Various Human Carcinomas, Platinum Coordination Complexes in Cancer Chemotherapy, Proceedings of the Fourth International Symposium on Platinum Coordination Complexes in Cancer Chemotherapy, Martinus Nijhoff Publishing, Boston, 1984.

3. Gilman A, Bonomi P, Dunne C, Anderson K, Graham J, Yordan EL, Wilbanks GD, Slayton RE: Estrogen and Progesterone Receptors in Carcinoma of the Cervix. Proc. ASCO March, 1984.

4. Yordan EL, Graham J, Reddy S, Lee MS, Eriksson J, Bonomi P, Slayton R, Wilbanks G: Treatment of Advanced Pelvic Malignancies with Simultaneous Cisplatin, 5-FU and Radiation Therapy. Proc. ASCO, May 1986.

5. Omura GA, Brady MF, Homesley H, Yordan E, Buchsbaum H, Major F, Miller A: Long Follow-up and Prognostic Factor Analysis in Very Advanced (Large Volume) Ovarian Carcinoma: The Gynecologic Oncology Group Experience. Proceedings ASCO, May 1989.

6. Sutton G, Bundy B, Omura G, Yordan E, Beecham J: Stage III Ovarian Tumors of Low Malignant Potential (LMP) Treated With Cisplatin-Combination Therapy. For the Gynecologic Oncology Group, SGO 2/89, Gynecologic Oncology 32:102, January 1989.

7. Reddy S, Saxena VS, Reddy S, Lee MS, Yordan E, Graham JE, Phillips R, Wilbanks GD: Results of Radio therapeutic Management of Primary Carcinoma of the Vagina. Gynecologic Oncology, 32:112, January 1989.

8. Yordan E, Jurado M, Kiel K, Reddy S, Kramer T, Calvo F, Roseman D, Graham J, Wilbanks G: Intraoperative Radiation Therapy (IORT) in Pelvic Malignancies. Gynecologic Oncology, 32:117, January 1989.

9. Willson J, Yordan E, Sielaff K, Tuttle R, Buchler D, Whisnant J, Borden E, Davis T: High Dose Huma Lymphoblastoid Interferon (HLBI) Administered as a 10-Day Continuous Infusion in Ovarian Cancer: An ECOG pilot study. Proceedings American Federation Clinical Research, 1984.

10. Yordan E, Straus A, Roseman D, Graham J, Wilbanks G: Peritoneovenous Shunting in the Management of Refractory Ascites From Gynecologic Malignancy. Proceedings ASCO, 1983.

11. Boente MP, Miller AW, McIntosh DG, Yordan EL, Graham JE, Beck D, Wilbanks GD, Marshall R, Reddy S, Saxena V. Stage II Endometrial Carcinoma: A Review of Long Term Survival and Treatment Options. Seventeenth Annual Meeting of the Western Association of Gynecologic Oncologists, Ramada Renaissance Hotel, San Francisco, California, May 17-20, 1989.

12. Reddy S, Lee M, Reddy S, Yordan EL, Graham J, Sarin P, Phillips AK, Hendrickson FR. Vaginal Recurrences of Endometrial Carcinoma: Results of Treatment and Patterns of Failure. Seventeenth Annual Meeting of the Western Association of Gynecologic Oncologists, Ramada Renaissance Hotel, San Francisco, California, May 17-20, 1989.

13. Markman M, Hakes T, Reichman B, Jones W, Hoskins W, Rubin S, Almadrones L, Yordan EL, Eriksson J, Lewis JL. Phase 2 Trial of Intraperitoneal (IP) Cisplatin (C) and Ara-C (A) in Refractory Ovarian Carcinoma (ROC), Gynecologic Oncology #36;2:290, February 1990.

14. Reichman B, Markman M, Hakes T, Hoskins W, Rubin S, Jones W, Almadrones L, Yordan E, Eriksson J, Lewis Jr. J: Intraperitoneal (IP) Cisplatin (C) and ARA-C (A) in Refractory Ovarian Carcinoma (ROC) A Phase 2 Trial. Proceedings of the American Society of Clinical Oncology #9, 611-158, March 1990; Proceedings of the Society of Gynecologic Oncologists, February 1990. Gynec. Oncol 36:290, 1990.

15. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Johnson M, Mortel R: Clinical and Surgical Pathologic Findings in Squamous Cell Carcinoma of the Vulva (A Gynecologic Oncology Group Study). Presented at 2nd Congress of the International Gynecologic Cancer Society, Toronto, Canada, October 1989.

16. Markman M, Hakes T, Reichman B, Hoskins W, Rubin S, Jones W, Almadrones L, Yordan EL, Eriksson J, Lewis JL: Multiple Day Intraperitoneal (IP) Treatment of Refractory Ovarian Cancer Employing A Regimen of Cisplatin (DDP) and Cytarabine (ARA-C). Proceedings of Eastern Section Meeting of the American Federation of Clinical Research.

17. Homesley H, Bundy B, Sedlis A, Yordan E, Berek J, Johnson A. Mortel R: Groin Lymph Node Surgical Status and Tumor Size are Independent Prognostic Factors in Squamous Cell Carcinoma of the Vulva (A Gynecologic Oncology Group Study). Presented at the 21st Annual Meeting of the Society of Gynecologic Oncologists, February 1990.

18. Boente M, Yordan E, McIntosh D, Davies S, Orandi Y, Kirschner C, Miller A, Marshall R, Graham J, Reddy S, Dolan T, Bergen S, and Wilbanks G. The Positive Endocervical Curettage (ECC) Prognostic Factors and Their Implications in Stage II Endometrial Carcinoma. Proceedings of the American Society of Clinical Oncology #9, 642:165, March 1990.

19. Harris J, Siziopikou K, Alan M, Wilbanks G, Yordan E, Braun D: The Induction of Tumoricidal Function in Regional Versus Systemic Macrophages From Patients with Solid Tumors. Proceedings ASCO, 1991.

20. Heaton D, Yordan E, Reddy S, Wilbanks G: Hyperfractionated Radiation Therapy and Concurrent 5-Fluorouracil and Cisplatin in Locally Advanced Endometrial Cancer. Gynecol. Oncol. 42:1:24:187, August 1991.

21. Boente M, Orandi Y, Yordan E, De Geest K, Kirschner C, Miller A, Reddy S, Wilbanks G: Recurrence Patterns and Complications Among Various Treatment Modalities in Stage II Endometrial Carcinoma. Gynecol. Oncol. 42:2:25:187, August 1991.

22. Homesley H, Bundy B, Sedlis A, Yordan E, Berek J, Jahshan M, Mortel R: Proposed Staging for Vulvar Carcinoma Based on Risk Group Analysis of the Independent Prognostic Factors for Survival (A Gynecologic Oncology Group Study). Proceedings of 3rd Biennial Meeting of the International Gynecologic Cancer Society, Page 10, Cairns, Australia, September 1991.

23. Perlow JH, Wigton T, Yordan EL, Graham J, Wool N, Wilbanks GD: Disseminated Pelvic Actinomycosis Presenting as Metastatic Carcinoma: Association with the Progestasert Intrauterine Device. Reviews of Infectious Diseases 13:1115-9, November-December 1991.

24. Behbakht K, Massad LS, Yordan E, Winkelman L, Eriksson J, De Geest K, Kirschner C, Lincoln S, Wilbanks G. A Bleomycin/Ifosfamide/Cisplatin Regimen Exhibits Poor Activity Against Recurrent Squamous Gynecologic Cancers. ASCO, #849, 12:266, Orlando, Florida, May 1993.

25. Behbakht K, Yordan E, Casey C, De Geest K, Massad S, Kirschner C, Wilbanks G. Prognostic Indicators of Survival in Advanced Endometrial Cancer. Proc ASCO, #833, 12:262, Orlando, Florida, May 1993.

26. Thigpen T, Blessing J, Homesley H, Malfetano J, DiSaia P, Yordan E. Phase III Trial of Doxorubicin +/- Cisplatin in Advanced or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group (GOG) Study. Proc ASCO, #830, 12:261, Orlando, Florida, May 1993.

27. Behbakht K, Yordan E, Casey C, De Geest K, Massad S, Kirschner C, Wilbanks G. Prognostic Indicators of Survival in Advanced Endometrial Cancer. Accepted at WAGO, Santa Monica, California, May 1993.

28. Behbakht K, Yordan E, Casey C, De Geest K, Massad S, Kirschner C, Wilbanks G. Prognostic Indicators of Survival in Advanced Endometrial Cancer. Presented at the 8th International Meeting of Gynecologic Oncology, Barcelona, Spain, June 1993.

29. Baker, Katherine MD, Reddy, Susheel BS, Lee, Myung-Sook MD, De Geest, Koen MD, Lincoln, Sarah MD, Sarin, Pramilla MD, Graham, James MD., Yordan Edgardo MD, and Reddy, Salitha MD. Salvage Whole Abdominal Radiation Therapy For Ovarian Cancer: A Twelve Year Experience, April 1996.

30. Lestingi T, Dolan J, Yordan E, Anthony A, and Joy M. A Phase I/II Evaluation of Escalating Dose Topotecan and Cisplatin in Recurrent, Platinum Sensitive Ovarian Cancer. Lutheran General Cancer Care Center, Park Ridge, IL and SmithKline Beecham Pharmaceuticals, Proceedings ASCO, New Orleans, Louisiana, May 2000.

VISITING PROFESSORSHIPS

1. Visiting Professor, Southern Puerto Rico Medical Society, Ponce, Puerto Rico, 1981

2. Visiting Lecturer, Institut Dexeus, Barcelona, Spain, 1986

2. Visiting Professor, Department of Obstetrics and Gynecology, Universidad de Navarra, Pamplona, Spain, 1987

3. Visiting Lecturer, Department of Obstetrics and Gynecology, Universidad (Complutense) de Madrid, Madrid, Spain, 1988

4. Magistral Lecturer, Department of Obstetrics and Gynecology, Universidad (Complutense) de Madrid, El Escorial, Spain, 1991

5. Visiting Lecturer, Annual Meeting of the Sociedad Española de Ginecología y Obstetricia, Zaragoza, Spain, 1991

6. Visiting Professor, Department of Obstetrics and Gynecology, Universidad de Navarra, Pamplona, Spain, 1991

7. Visiting Lecturer, Centro Médico Nacional Militar, Mexico City, Mexico, 1992

8. Visiting Lecturer, Department of Obstetrics and Gynecology, Universidad de Costa Rica, San José, Costa Rica, 1992

9. Guest Lecturer, Peruvian American Medical Society, Lima, Perú, 1993

10. Visiting Lecturer, Centro Médico Nacional Militar, Mexico City, Mexico, 1994

11. Visiting Profesor, School of Medicine, University of Porto Alegre, Porto Alegre, Brazil

12. Guest Lecturer, Department of Obstetrics and Gynecology, Los Angeles County – University of Southern California, 1996

13. Visiting Lecturer, Centro Médico Nacional Militar, Mexico City, Mexico, 1996

14. Visiting Lecturer, Ponce Medical School, Ponce, Puerto Rico, 1996

15. Visiting Professor and Surgeon, 2nd International Course of Gynecologic Surgery, Hospital de Clínicas, Department of Obstetrics and Gynecology, Universidad de Buenos Aires, Buenos Aires, Argentina, 1998

16. Visiting Lecturer, Annual Meeting of the Sociedad Española de Ginecología y Obstetricia, Sección de Ginecología Oncológica, El Escorial, Spain, 2002

17. Guest Special Lecturer, Bi-Ennial Meeting of the Asociación Argentina de Ginecología Oncológica, Buenos Aires, Argentina, 2005. Awarded honorary membership in Society.

18. Visiting Lecturer, Department of Obstetrics and Gynecology, Geisinger Clinic, Pennsylvania, 2007

19. Visiting Professor, M. D. Anderson International – Madrid Medical Center, Madrid, Spain, August 2007

20. Guest Participant, 1st International Symposium on Cervical Cancer, M. D. Anderson International – Madrid Medical Center, Madrid, Spain, February 2008